LONDON and SINGAPORE, Nov 25 (Bernama-GLOBE NEWSWIRE) –Claritas HealthTech (“Claritas”), a healthcare technology company specializing in medical image enhancement and Artificial Intelligence (AI) assisted diagnostic tools, announces today that it has been awarded access to the National Covid-19 Chest Imaging Database (NCCID) curated by the AI Lab NHSE, after a rigorous and peer-reviewed assessment process to evaluate the benefits of iRADTM across modalities and conditions.
Claritas will carry out research using iRADTM, its image enhancement Software as a Medical Device (SaMD), with leading UK-based consultant Radiologists. The study will evaluate data across modalities (X-Rays, CT, and MRI) using multiple clinical, operational, and quality parameters for the benefit of patient outcomes.